Approval Year
| Substance Class |
Structurally Diverse
Created
by
admin
on
Edited
Tue Apr 01 20:45:26 GMT 2025
by
admin
on
Tue Apr 01 20:45:26 GMT 2025
|
| Source Materials Class | ORGANISM |
| Source Materials Type | ALLOGENIC HUMAN |
| Source Materials State | LIVE |
| Source Materials Parent | |
| Part | bone marrow |
| Fraction Material Type | cell |
| Fraction Name | mesenchymal stem |
| Record UNII |
OEN4982XNW
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
849521
Created by
admin on Tue Apr 01 20:45:26 GMT 2025 , Edited by admin on Tue Apr 01 20:45:26 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
OEN4982XNW
Created by
admin on Tue Apr 01 20:45:26 GMT 2025 , Edited by admin on Tue Apr 01 20:45:26 GMT 2025
|
PRIMARY | |||
|
100000180158
Created by
admin on Tue Apr 01 20:45:26 GMT 2025 , Edited by admin on Tue Apr 01 20:45:26 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| ANTIGEN NOT EXPRESSED | BIOLOGICAL |
|
||||
| ANTIGEN NOT EXPRESSED | BIOLOGICAL |
|
PW3DO1LF7X
HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR
(not present in database)
|
|||
| ANTIGEN EXPRESSED | BIOLOGICAL |
|
||||
| ANTIGEN EXPRESSED | BIOLOGICAL |
|
||||
| ANTIGEN NOT EXPRESSED | BIOLOGICAL |
|
||||
| ANTIGEN NOT EXPRESSED | BIOLOGICAL |
|
||||
| ANTIGEN EXPRESSED | BIOLOGICAL |
|
||||
| ANTIGEN NOT EXPRESSED | BIOLOGICAL |
|
